A report by the campaign group Malaria No More UK found that young people entering the workforce in sub-Saharan Africa missed an average of nearly 100 days of school due to malaria infections. Released on November 12, 2026, the research suggests these absences lead to a 10 percent reduction in lifetime earnings for affected individuals.
The findings come as international health organizations express concern over a potential resurgence of the disease. Current data shows over 280 million annual cases, which is approximately 20 percent higher than in 2015. While malaria kills an estimated 610,000 people annually—most of whom are children aged five or under—the report focuses on the long-term economic and educational impact on those who survive the mosquito-borne illness.
Modelling conducted by Impact Global Health for the report indicates that a 30 percent reduction in malaria prevention funding would lead to an 18 percent increase in lost school days for children born in 2026. The African Leaders Malaria Alliance estimated that current trends in international aid could result in such a 30 percent funding shortfall in the near future. Campaigners attributed the current challenges to a "perfect storm" of insecticide resistance, extreme weather, and budget cuts.
The financial impact extends to global health institutions. Malaria No More UK stated that a 30 percent drop in international aid—which the African Leaders Malaria Alliance warns is a possibility—would directly increase school absenteeism for the current generation of infants. This sets a precedent for how fluctuations in foreign aid from donor nations like the UK can influence long-term economic growth and educational attainment in developing regions. In the day-to-day, a lack of funding would mean fewer rapid test kits and limited access to the medical care required to keep students in classrooms during malaria season.
What happens next: Malaria No More UK is calling on international donors, including the UK government, to maintain or increase investments in the Global Fund to Fight AIDS, Tuberculosis and Malaria, as well as Gavi, the Vaccine Alliance. While specific voting dates or legislative deadlines for aid budgets were not reported, the group emphasized that the scale of the response must match the rise in cases to prevent further educational losses. The report suggests that increased funding for rapid testing and education on early symptoms could mitigate some of these effects. No specific effective date for new funding or policy changes was provided in the source.